These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22149216)

  • 1. Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against Parkinson's disease in the MPTP-induced mice model.
    Xiang Y; Wu Q; Liang L; Wang X; Wang J; Zhang X; Pu X; Zhang Q
    J Drug Target; 2012 Jan; 20(1):67-75. PubMed ID: 22149216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
    Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
    Lyons SA; O'Neal J; Sontheimer H
    Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of Parkinson's disease].
    Shu D; He J; Chen J
    Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(19):2494-7. PubMed ID: 20067021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
    Zhang HN; An CN; Zhang HN; Pu XP
    Neurosci Lett; 2010 Apr; 474(2):99-103. PubMed ID: 20227465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
    Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
    Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3.
    Qin C; He B; Dai W; Lin Z; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Biomaterials; 2014 Jul; 35(22):5908-20. PubMed ID: 24743031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.
    Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG
    J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.
    Kreisler A; Gelé P; Wiart JF; Lhermitte M; Destée A; Bordet R
    Brain Res; 2007 Mar; 1135(1):77-84. PubMed ID: 17196944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease.
    He XJ; Yamauchi H; Uetsuka K; Nakayama H
    Neurotoxicology; 2008 May; 29(3):413-20. PubMed ID: 18387672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.
    Monaghan MM; Leddy L; Sung ML; Albinson K; Kubek K; Pangalos MN; Reinhart PH; Zaleska MM; Comery TA
    Neurodegener Dis; 2010; 7(1-3):153-9. PubMed ID: 20197696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease.
    Kim JI; Yang EJ; Lee MS; Kim YS; Huh Y; Cho IH; Kang S; Koh HK
    Int J Neurosci; 2011 Apr; 121(4):209-17. PubMed ID: 21265705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.